CC BY-NC-ND 4.0 · J Reconstr Microsurg Open 2018; 03(01): e32-e40
DOI: 10.1055/s-0038-1642626
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Impact of Surgically and Radiologically Detected Incidental Internal Mammary Lymph Node Enlargement in Breast Cancer Patients Undergoing Free-Flap Breast Reconstruction

Haitham H. Khalil
1   Department of Oncoplasty and Reconstructive Surgery, Good Hope Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
,
Maninder Kalkat
2   Department of Thoracic Surgery, Heartlands Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
,
Marco N. Malahias
1   Department of Oncoplasty and Reconstructive Surgery, Good Hope Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
,
Saif Rhobaye
1   Department of Oncoplasty and Reconstructive Surgery, Good Hope Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
,
Tarek Ashour
1   Department of Oncoplasty and Reconstructive Surgery, Good Hope Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
3   Department of Plastic and Reconstructive Surgery, Cairo University Hospitals, Cairo, Egypt
,
Tahir Faroq
4   Department of Breast Surgery, Good Hope Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
,
Amar Shimal
5   Department of Radiology, Good Hope Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
,
Medy Tsalic
6   Department of Oncology, Solihull Hospital, University Hospitals of Birmingham, Solihull, West Midlands, United Kingdom
,
Babu Naidu
2   Department of Thoracic Surgery, Heartlands Hospital, University Hospitals of Birmingham, Birmingham, West Midlands, United Kingdom
› Author Affiliations
Further Information

Publication History

30 September 2017

05 March 2018

Publication Date:
11 May 2018 (online)

Abstract

Background The internal mammary lymph node (IMLN) basin is considered the second most important regional nodal basin in breast cancer. IMLNs are often not detected radiologically and left untreated, with symptomatic recurrence being 0.1%. Challenges in accessibility have been an obstacle in achieving a comprehensive treatment plan, especially with undetermined and radiologically enlarged IMLN. Free autologous tissue breast reconstruction is considered the gold standard, and the familiarity of microvascular surgeons in using the internal mammary vessels (IMVs) puts them in a unique position to shed more light on the natural pathological process of IMLN metastases.

Materials and Methods A retrospective data analysis study was conducted evaluating 270 patients who underwent 307 free flaps for breast reconstruction using the IMV in the period between 2009 and 2017. Patient's demographics and clinicopathological data including IMLN harvest, radiological, operative details, adjuvant therapy, postoperative morbidity, and follow-up outcome data were analyzed.

Results Eighty-nine enlarged IMLNs were surgically retrieved from 30.7% (83/270) of the patients (73 delayed, 10 immediate breast reconstructions) with an age range of 29 to 77 years (mean: 45). Eighty six were incidentally encountered during surgery, whereas in three, the enlarged IMLN was preoperatively, radiologically determined and biopsied during computed tomography (CT) scan staging and was retrieved subsequently during surgery. IMLN metastases were confirmed in 8.4% (7/83) of the patients in whom IMLNs were retrieved with subsequent modification of the proposed adjuvant therapy. The follow-up period ranged from 3 to 84 months (mean: 42) for the involved IMLN patients. Two patients (28% [2/7]) showed signs of disease progression with mortality.

Conclusion Microvascular surgeons in a multidisciplinary setting would provide a valuable role in improving outcomes of patients with IMLN metastases through better diagnosis and staging of incidentally enlarged metastatic IMLN and provision of an effective approach for locoregional disease control.

Note

Part of this work has been presented as an oral presentation in the Association of Breast Surgery Meeting, 2015, Bournemouth, United Kingdom, with the abstract published in the official journal, European Journal of Surgical Oncology, June 2015, Vol.41(6):55–58.


 
  • References

  • 1 Koo MY, Lee SK, Bae SY. , et al. Long-term outcome of internal mammary lymph node detected by lymphoscintigraphy in early breast cancer. J Breast Cancer 2012; 15 (01) 98-104
  • 2 Veronesi U, Cascinelli N, Greco M. , et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202 (06) 702-707
  • 3 Paredes P, Vidal-Sicart S, Zanón G. , et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging 2005; 32 (11) 1283-1287
  • 4 Carcoforo P, Sortini D, Feggi L. , et al. Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. Ann Surg Oncol 2006; 13 (10) 1338-1343
  • 5 Mansel RE, Goyal A, Newcombe RG. ; ALMANAC Trialists Group. Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer 2004; 5 (04) 279-284
  • 6 Chagpar AB, Kehdy F, Scoggins CR. , et al. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg 2005; 190 (04) 557-562
  • 7 Wright EJ, Momeni A, Kraneburg UM. , et al. Clinical significance of internal mammary lymph node biopsy during microsurgical breast reconstruction: review of 264 cases. Plast Reconstr Surg 2016; 137 (06) 917e-922e
  • 8 Long H, Lin Z, Situ D, Ma G, Zheng Y, Rong T. Stage migration and therapy modification after thoracoscopic internal mammary lymph node dissection in breast cancer patients. Breast 2011; 20 (02) 129-133
  • 9 Caudle AS, Yi M, Hoffman KE. , et al. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol 2014; 21 (01) 60-65
  • 10 Yao MS, Kurland BF, Smith AH. , et al. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol 2007; 14 (10) 2985-2993
  • 11 van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001; 234 (01) 79-84
  • 12 Madsen E, Gobardhan P, Bongers V. , et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 2007; 14 (04) 1486-1492
  • 13 Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review. J Clin Oncol 2008; 26 (30) 4981-4989
  • 14 Cranenbroek S, van der Sangen MJ, Kuijt GP, Voogd AC. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat 2005; 89 (03) 271-275
  • 15 Chen L, Gu Y, Leaw S. , et al. Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer. BMC Cancer 2010; 10: 479
  • 16 Farrús B, Vidal-Sicart S, Velasco M. , et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys 2004; 60 (03) 715-721
  • 17 Bourre JC, Payan R, Collomb D. , et al. Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?. Eur J Nucl Med Mol Imaging 2009; 36 (05) 758-764
  • 18 Fowble B, Solin LJ, Schultz DJ, Goodman RL. Frequency, sites of relapse and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 1989; 17 (04) 703-710
  • 19 Scott Jr WW, Fishman EK. Detection of internal mammary lymph node enlargement: comparison of CT scans and conventional roentgenograms. Clin Imaging 1991; 15 (04) 268-272
  • 20 Klauber-DeMore N, Bevilacqua JL, Van Zee KJ, Borgen P, Cody III HS. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 2001; 193 (05) 547-555
  • 21 Sugg SL, Ferguson DJ, Posner MC, Heimann R. Should internal mammary nodes be sampled in the sentinel lymph node era?. Ann Surg Oncol 2000; 7 (03) 188-192
  • 22 Purushotham AD, Cariati M. Internal mammary nodes and breast cancer. Br J Surg 2005; 92 (02) 131-132
  • 23 Yu JT, Provenzano E, Forouhi P, Malata CM. An evaluation of incidental metastases to internal mammary lymph nodes detected during microvascular abdominal free flap breast reconstruction. J Plast Reconstr Aesthet Surg 2011; 64 (06) 716-721
  • 24 Johnson N, Soot L, Nelson J. , et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 2000; 179 (05) 386-388
  • 25 Andree C, Schmidt VJ, Munder BI. , et al. Detecting of breast cancer metastasis by means of regional lymph node sampling during autologous breast reconstruction--a screening of 519 consecutive patients. Med Sci Monit 2012; 18 (10) CR605-CR610
  • 26 Schaverien MV, Purdie CA, Munnoch DA. Clinical value of internal mammary lymph node metastases found incidentally during free flap recipient vessel exposure. Eur J Surg Oncol 2013; 39 (06) 608-612
  • 27 Wong KY, Yu JT, Mahler-Araujo B, Forouhi P, Malata CM. Opportunistic internal mammary lymph node biopsy during microvascular free flap breast reconstruction: a useful technique?. Int J Surg 2013; 11 (09) 1027-1028
  • 28 Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999; 35 (09) 1320-1325
  • 29 Veronesi U, Arnone P, Veronesi P. , et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 2008; 19 (09) 1553-1560
  • 30 Zhang YJ, Oh JL, Whitman GJ. , et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. Int J Radiat Oncol Biol Phys 2010; 77 (04) 1113-1119
  • 31 Ricci JA, Epstein S, Momoh AO, Lin SJ, Singhal D, Lee BT. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. J Surg Res 2017; 218: 108-116
  • 32 van Geel AN, Wouters MW, van der Pol C, Schmitz PI, Lans T. Chest wall resection for internal mammary lymph node metastases of breast cancer. Breast 2009; 18 (02) 94-99
  • 33 Petrella F, Radice D, Borri A. , et al. Chest wall resection and reconstruction for locally recurrent breast cancer: from technical aspects to biological assessment. Surgeon 2016; 14 (01) 26-32
  • 34 Khalil HH, Malahias MN, Balasubramanian B. , et al. Multidisciplinary oncoplastic approach reduces infection in chest wall resection and reconstruction for malignant chest wall tumors. Plast Reconstr Surg Glob Open 2016; 4 (07) e809
  • 35 Basta MN, Fischer JP, Lotano VE, Kovach SJ. The thoracoplastic approach to chest wall reconstruction: preliminary results of a multidisciplinary approach to minimize morbidity. Plast Reconstr Surg 2014; 134 (06) 959e-967e
  • 36 Huang O, Wang L, Shen K. , et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 2008; 107 (03) 379-387
  • 37 Colleoni M, Zahrieh D, Gelber RD. , et al. Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol 2005; 23 (07) 1390-1400
  • 38 Noushi F, Spillane AJ, Uren RF, Gebski V. Internal mammary lymph node metastasis in breast cancer: predictive models to assist with prognostic influence. Breast 2011; 20 (03) 278-283